Chief Financial Officer
David brings over twenty years of corporate finance and business development know-how with a strong track record of improving profits, productivity and scalability while effectively managing risk . He is passionate about advancing disruptive technology, an interest first developed working on PEM fuel cell alliances at General Motors. David comes to us from Science 37, an innovative contract research organization in the emerging distributed clinical trial space, where he served as CFO. In all, David’s experience spans small startups to Fortune 50 multinationals in business strategy, M&A, capital planning, financing, risk management, turnarounds and workouts, and organizational development. David earned his BS in Accounting from New York University and MBA from Columbia Business School.